Patients who met the inclusion criteria were treated with endovascular radiofrequency ablation and desympathetic nerve surgery. After enrollment, endovascular radiofrequency ablation and desympathetic surgery were performed. After radiofrequency ablation, the safety and efficacy of follow-up treatment will be carried out every 1 month or so, including blood routine, liver and kidney function, tumor indicators, abdominal CT/magnetic resonance, etc.
Clinically or pathologically confirmed hepatocellular carcinoma (HCC)
Locally progressed or distant metastatic unresectable advanced HCC
Progressed after second-line therapy
Agree to participate in the study and sign the informed consent form
Not suitable for ablation surgery
Pregnant, lactating and planning to become pregnant
Orthostatic hypotension
Mixed liver cancer
Single group
endovascular radiofrequency ablation and desympathetic nerve surgery
Procedure/Surgeryendovascular radiofrequency ablation and desympathetic nerve surgery
ORR
Objective Response Rate
PFS
Progression Free Survival
DCR
disease control rate
Click on the lead sponsor to view all of their trials.
